Science — Noozify Original — October 5, 2026

Optogenetics: The Nobel for a Light Switch Borrowed From Algae

By Adam Canissario

Watch the story in half a minute

Chlamydomonas reinhardtii is a single green cell with two whip-like tails, and it spends its life doing one thing well. It swims toward light. Working out how it manages that, with nothing more than a tiny eyespot and no nervous system at all, looked like a question for a small corner of biology. On October 5th it became the basis for this year's Nobel Prize in Physiology or Medicine.

The Nobel Assembly at the Karolinska Institutet awarded the prize jointly to Karl Deisseroth of Stanford University, Peter Hegemann of Humboldt University in Berlin, and Georg Nagel of the University of Würzburg, "for their discoveries concerning light-gated ion channels and optogenetics." The assembly said the three "have laid the foundation of a new era in neuroscience," and described optogenetics as a method that shows "how nerve cells shape memories, feelings and behaviours in the living brain." It is a prize for a tool rather than for a single finding, and the tool's story runs from a freshwater alga to a blind man counting glasses on a table.

To see why the alga mattered, it helps to know how a nerve cell talks. The inside of a resting neuron carries a slight negative charge compared with the outside. The cell fires when charged particles, called ions, rush in through tiny pores in its outer wall and briefly flip that charge, sending an electrical signal along the cell. Those pores, called ion channels, usually open in response to a chemical messenger or to a change in voltage. What Hegemann and Nagel found in Chlamydomonas was a pore that opens in response to light. Most light detectors in nature, including the ones in our eyes, work in two steps. One protein catches the light, then passes the message along a chain of chemical reactions before anything electrical happens. The alga's protein, channelrhodopsin, skips the relay. It catches the light and opens the pore itself, all in one molecule.

In a 2003 paper in the Proceedings of the National Academy of Sciences, Hegemann, Nagel, and their colleagues described channelrhodopsin-2 as "a directly light-switched cation channel" that "opens rapidly after absorption of a photon." Shine blue light on it and charged particles pour into the cell. The alga uses that jolt to steer. The team then took the gene for channelrhodopsin, the stretch of the alga's DNA that holds the instructions for building the protein, and put it into frog eggs and human kidney cells. Those cells began making the protein themselves, and light switched it on there too. The researchers added a line that reads in hindsight like a forecast, noting that the protein "may be used to depolarize small or large cells, simply by illumination." To depolarize a cell is to shift its electrical charge in the direction that, in a nerve cell, sets off a signal. In plain terms, light alone might be enough to make a neuron fire.

Neuroscientists had wanted something like that for decades. Their methods could record which neurons were active during a behavior, or destroy a region and see what stopped working, but neither could switch one type of cell on and off on command, at the speed the brain itself works. Electrodes stimulate everything nearby. Drugs act over minutes. The question of whether a particular set of cells causes a behavior, rather than merely accompanying it, kept running into that wall.

Deisseroth, a psychiatrist as well as a bioengineer, saw the alga's channel as a way through. In a 2005 paper in Nature Neuroscience, his lab used a harmless, modified virus as a delivery vehicle, carrying the alga's instructions for channelrhodopsin into rat neurons so that the neurons built the light-switched pores into their own outer walls. The team showed "reliable, millisecond-timescale control of neuronal spiking." Each flash of blue light made a neuron fire, on schedule, as many times as the experimenters chose. Because the instructions could be written so that only one chosen type of cell would read them, the light affected those cells and left their neighbors alone. His group then worked out how to run optical fibers into the brains of living mice, which turned a laboratory demonstration into something researchers could use in animals that move, eat, and remember.

What followed was a decade in which neuroscience stopped merely watching the brain and began testing it. Optogenetics has been used to identify the cells that govern eating, sociability, and aggression, and to study the circuits disrupted in Parkinson's disease, epilepsy, depression, and addiction, according to Scientific American. One of the most vivid results came from MIT in 2013, when Susumu Tonegawa's lab planted a false memory in mice. The researchers tagged the neurons that recorded a harmless chamber, then reactivated them with light while the animals received a mild shock somewhere else. Back in the first chamber, the mice froze in fear, "even though they had never been shocked there," as the study's co-lead author Steve Ramirez put it.

The technique has also reached a human eye. In 2021, a team led by José-Alain Sahel reported in Nature Medicine that a man blinded by retinitis pigmentosa, an inherited disease that destroys the retina's light-sensing cells, had regained partial vision after his remaining retinal neurons were given an optogenetic protein that responds to amber light. Wearing goggles with a camera that converts the scene into amber pulses, he could locate, touch, and count objects on a table, touching a notebook 92 percent of the time and counting glass tumblers correctly 63 percent of the time. Without the goggles he could not do it. It was a proof of concept rather than a cure, and the researchers described it as the first reported case of partial functional recovery in a neurodegenerative disease after optogenetic therapy.

A prize like this also invites the question of who is missing from it. The Nobel can be shared by no more than three people, and optogenetics had more than three parents. Gero Miesenböck, now at Oxford, used light-sensitive proteins from fruit-fly eyes to make neurons fire as early as 2002, and he shared Columbia's Horwitz Prize for optogenetics in 2022 with Deisseroth and Hegemann. The 2005 paper itself had five authors. Its first author, Ed Boyden, was then a graduate student and now leads his own lab at MIT, and another, Feng Zhang, was a graduate student in Deisseroth's lab who, as STAT has reported, helped invent the technique. Zhang later pioneered CRISPR-Cas9 as a genome-editing tool in human cells, the technology behind the first CRISPR therapy cleared for toddlers. The committee's choice of Nagel, whose name sits on both the 2003 discovery and the 2005 application, reads as a statement that the protein and its use are one story.

That story is a familiar one for the Nobel, and an argument the prize keeps making on behalf of research no one can justify in advance. "This was a brilliant idea, but it seemed entirely far-fetched," Abdel El Manira of the Karolinska Institutet said, in Scientific American's account of the announcement. Hegemann was trying to understand how a microbe finds the sun. Nagel was measuring currents across membranes. Neither was looking for a way to switch off fear in a mouse or to return a sliver of sight to a blind man, and neither of those things would exist without the alga that swims toward the light.